Zdrowie i gospodarka · 28/12/2015

FDA Announces Externally-Led Patient-Focused Drug Development Meetings to Expand Patient Perspective

The FDA is launching externally-led patient-focused drug development meetings to gather more patient input on various diseases beyond the initial scope of the Prescription Drug User Fee Act (PDUFA V), building on the Patient-Focused Drug Development (PFDD) initiative